ArcelorMittal (NYSE:MT – Get Free Report) has earned an average rating of “Hold” from the nine research firms that are presently covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among analysts […]

Summit Therapeutics PLC (NASDAQ:SMMT – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eighteen research firms that are covering the stock, MarketBeat reports. Four analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, eleven have given a buy recommendation and one has issued […]